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ABSTRACT
The aim of the current study is to determine the protective and therapeutic effects of linalool against
carbon tetrachloride (CCl4)-induced hepatoxicity and nephrotoxicity. Six-week-old male Wistar rats were
divided into five groups: Control group (a regular diet); CCl4 group (1ml/kg dissolved in olive oil, intra-
peritoneally at 14th day); pretreatment group (25mg/kg linalool dailyþCCl4 14thday); post-treatment
group (25mg/kg linalool 2, 6, 24, and 48h after the injection of CCl4 at 14
th day); and linalool group
(25mg/kg linalool daily, orally). All animals were sacrificed, tissue and blood samples were collected to
analysis. Administration of CCl4 resulted in a marked increase in hepatic (aspartate aminotransferase,
alanine transaminase, and alkaline phosphatase) and renal (blood urea nitrogen and creatinine)
markers. Also, CCl4 resulted in pathological damages, a significant increase in the concentration of
malondialdehyde , tumor necrosis factor-alpha, and Interleukin 6 , expression of nuclear factor kappa-
light-chain-enhancer of activated B cells and a significant decrease in the levels of serum total protein,
serum albumin, and antioxidants. However, in pretreatment and post treatment groups, linalool signifi-
cantly inhibited CCl4- induced hepatic and nephric damages. These results demonstrate that linalool
has protective and therapeutic effects in an in vitro model of CCL4-induced hepatic and nephric dam-
age, proposing linalool as a potential therapeutic agent against chemical and drug induced hepatotox-
icity and nephrotoxicity.
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Introduction
The liver and kidneys are main organs affected by drug and
chemical toxicity (Zhang et al. 2007). The liver is the main
organ where exogenous and endogenous chemicals are
metabolized and finally excreted (Almazroo et al. 2017). As a
consequence, hepatocytes (liver cells) are exposed to remark-
able concentrations of these chemicals and drugs, which can
lead to cell death, hepatoxicity, liver dysfunction, and even
organ failure (Russmann et al. 2009). The kidney has a key
role in the regulation of acid-base balance, electrolyte com-
position, and extracellular fluid volume, and in the excretion
of metabolic wastes (Raghavendra and Vidya 2013).
Moreover, the kidney synthesizes and releases hormones, and
metabolizes vitamin D3 to the active form (Gekle 2017).
Therefore, the functional integrity of the mammalian liver
and kidneys is vital to total body homeostasis (Burcham
2014). A toxic insult to the liver and kidney could disrupt any
or all of these activities and could have profound effects on
mammalians (Zhang et al. 2012). Therefore, the liver and the
kidneys are more commonly involved in overt organ toxicity
than most other tissues (Zhang et al. 2012). Accidental or
deliberate toxicity with drugs can cause life-threatening liver
and kidney damages. Moreover, these medicinal risks, liver
and kidney injuries accompany exposure to different chemi-
cals in the environment or workplace. Still chemicals such as
food contaminants that harm these excretory organs are con-
sumed (Burcham 2014). Therefore, protecting the liver and
kidney against these agents is inevitable. Natural compounds
found in plants have long been shown to play an important
role in inhibiting liver and kidney toxicity (Nale et al. 2012).
Herbal medicines have a long history over than 7000 years
in the treatment of many diseases. Using natural compounds
to treat diseases mainly in the developing countries, is still
the pillar of near 75–80% of the treatment in the world (Ekor
2014). Because of better compatibility with the human body,
lesser side effects and better cultural acceptability, these
compounds are used frequently for primary health care (Ekor
2014). Also, a major increase in their use in the developed
countries have seen in the last few years. Nowadays, there is
a bipolarized market for the active compounds: those natural
ingredients that are requested by patients and those chem-
ically produced by the pharmaceutical companies (Atanasov
et al. 2015). Many of these agents can have ameliorative
effects against drugs and chemicals toxicities (Abdel-Daim
et al. 2016). One of these natural products is linalool (LIN),
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which found in essential oils of plants such as mint, basil,
and coriander. Linalool has several pharmacological effects
including antibacterial, antimicrobial, anti-inflammatory, anti-
viral, anesthetic, and analgesic effects (Sharifi et al. 2017).
Previous studies showed that linalool, is a competitive antag-
onist of N-methyl d-aspartate (NMDA) receptors and produ-
ces analgesic properties via brain opioids when it inhibits
NMDA receptor activity (Batista et al. 2008). In addition, the
hypolipidemic, antihyperglycemic, and antioxidant properties
of linalool, its preventive effect on proteinuria and its thera-
peutic effect on kidney function were evidenced. It was sug-
gested that some monoterpenes obtained from plants
inhibited and decrease tumor growth. Therefore, recent
investigations have focused on the chemotherapeutic or
chemo-preventive potential of linalool (Kamatou and Viljoen
2008). A recent study has shown that linalool has protective
effect against glutamate-induced oxidative stress and excito-
toxity (Sabogal-Guaqueta et al. 2019). Oner et al. (2019)
proved that administration linalool with doxorubicin can
remove cardiomyopathy symptom induced by this drug. It
has been reported that the plasma concentration of linalool
reaches about 10min at the first minor peak, the second
major peak reaches in about 40min, and then the linalool
concentration in the plasma decreased rapidly (Shi
et al. 2016).
Carbon tetrachloride (CCl4) is widely used as a model for
induction of liver and kidney damages in rats to investigate
potential therapeutic effect of new agents (Suzuki et al.
2015). This chemical is metabolized to active metabolites
such as trichloromethyl-free radicals and peroxyl radical by
the cytochrome P450 enzymes, which then initiate oxidative
damages, cell death, and inflammation (Dai et al. 2018a).
Whereas, linalool has previously been shown to exhibit anti-
inflammatory and antioxidant properties and to the best of
our knowledge, there is no literature on the effects of linalool
on hepatoxicity and nephrotoxicity. The aim of the present
study was to determine the protective and therapeutic
effects of linalool, on tetrachloride-induced hepatoxicity and
nephrotoxicity in rats using histopathologic, genes analysis
and biochemical methods.
Materials and methods
Chemicals and kits
Hydrogen peroxide, methanol, thiobarbituric acid, bovine
serum albumin (BSA), Coomassie blue, CCl4, iron sulfate, ferric
chloride, sodium acetate, ketamine, xylazine, and butanol
were purchased from Merck Company (Darmstadt, Germany).
The Wistar albino rats were purchased from the Baquatollah
University of Medical Sciences (Tehran, Iran). The kits for
superoxide dismutase (SOD) and glutathione peroxidase
(GPx) were purchased from Randox Company (Crumlin, UK).
The kits for assaying of aspartate aminotransferase (AST), ala-
nine transaminase (ALT), alkaline phosphatase (ALP), blood
urea nitrogen (BUN), creatinine, bilirubin, serum total protein,
and serum albumin levels were purchased from Pars-Azmoon
Company (Tehran, Iran). The kits for assaying tumor necrosis
factor-alpha (TNF-a) and interleukin-6 (IL-6) levels were
purchased from R&D Systems Europe, Ltd. (Abingdon, UK).
Linalool (3,7-dimethyl-1, 6-octadien-3-ol) with a purity of
about 99% and CAS number 78-70-6 was purchased from
Sigma-Aldrich (St Louis, MO). Linalool was freshly prepared
before use and dissolved in normal saline 0.9% wt/vol.
Animals
Male Wistar rats weighing 200 ± 20 g was purchased from the
Baquatollah University of Medical Sciences (Tehran, Iran) and
maintained under a standard dark-light cycle (lights on
between 7:00and 7:00am) at room temperature (22 ± 2 C).
These conditions were maintained constantly throughout the
experiments. This study was approved by the Ethics
Committee at the Ardabil University of Medical Sciences with
ethics codes IR.ARUMS.REC.1397.120 and performed strictly in
accordance with institutional and international guide for ani-
mal care.
Experimental design
Thirty male Wistar rats weighing 200± 20 g, aged eight
weeks, were selected randomly and given free access to
water and food. After two weeks of acclimation, the animals
were assigned for experimental procedures. The animals
were divided into five subgroups: controls (normal rats n¼ 6)
gained free access to food and water; the CCl4 group (n¼ 6)
was given 1ml/kg of CCl4, dissolved in olive oil, through
intraperitoneally at 14th day; the pretreatment group (25 g
mg/kg LIN for 14 days plus single dose of 1mg/kg CCl4); the
post-treatment group (25mg/kg LIN 2, 6, 24, and 48 h after
the injection of CCl4 at 14th day), and the LIN group was
given normal diet and administered LIN orally (25mg/kg) for
14 days. The dose of CCl4 and LIN was determined based on
previous studies (Dai et al. 2018a, Sabogal-Guaqueta et al.
2019). At the end of the experimental procedures, all animals
were weighed and then anesthetized using a combination of
xylazine (10mg/kg) and ketamine (10mg/kg) administered
via intraperitoneal (i.p.) injections. Liver and kidney tissues
were taken for RNA extraction and gene expression (reverse
transcription polymerase chain reaction, RT-PCR) as well as
for histopathology and antioxidant capacity.
Serum extraction and chemistry analysis
Blood was collected directly from their heart using hepari-
nized capillary tubes. The blood samples were centrifuged at
3000 rpm for 10min and the supernatants (serums) were
transferred into 0.5ml vials and were frozen at 80 C for the
subsequent biochemical tests and the analysis of inflamma-
tory factors. Serum creatinine, BUN, bilirubin, albumin, total
protein, ALT, AST, and ALP was measured using commercially
available kits based on spectrophotometric analysis.
Determination of liver and kidney antioxidant activity
For malondialdehyde (MDA), total antioxidant capacity (TAC),
superoxide dismutase (SOD), catalase (CAT), glutathione
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peroxidase (GPx), catalase activity measurements, 200mg of
liver or kidney slices was homogenized in 2ml of homogen-
ization buffer (50mM potassium phosphate buffer; PBS, pH
7.4). The homogenized tissues were centrifuged at
10 000 rpm for 2min. The supernatants were centrifuged
again at 12 000 rpm for 20min to obtain the pure superna-
tants. The final obtained supernatants were used for the
measurement of the antioxidant activity. The activities of
SOD, CAT, GPx, and TAC were determined using commercially
available kits based on spectrophotometric analysis by
StatFax 3000 ELISA reader . Results of SOD, CAT, GPx, and
TAC activities were calculated according to the manufac-
turer’s instructions.
Liver and kidney histopathology
At the end of the experimental procedures, livers and kidneys
of all experimental animals were removed. The removed tis-
sues were fixed in a buffered neutral formalin solution (10%).
Fixed tissues were processed routinely including washing,
dehydration, clearing, paraffin embedding, casting, and were
sectioned to 4–5 mm thickness for using in hematoxylin and
eosin (H&E) staining. To examine the histological alterations
12 images were selected randomly in each sample and the
histological index was calculated semi-quantitatively using a
scale of 0–3: (0) none, (1) mild, (2) moderate, and (3) severe
damage. The investigated damages include degenerated
cells, necrotic cells, vacuolation, cell detachment, and
lymphocyte infiltration (Peng et al. 2018).
Real time quantitative RT-PCR analysis
Total RNA was extracted from liver samples with RNX- Plus (Cat
No. EX 6101, SINACLON, Tehran, Iran) according to the kit
protocols. Two micrograms of total RNA were reversely tran-
scribed into cDNA by using SMOBIO strand cDNA synthesis kit
(lot No #CHRP 051901430-8, Taiwan), according to the man-
ufacturer’s instructions. Quantitative RT- PCR was carried out
using TB Green Premix Ex TaqTM II (cat#RR820Q, TaKaRa, China)
kit on LightCyclerVR 96 System (Roche Applied Science,
Mannheim, Germany). Actb was applied as housekeeping gene
for normalization of gene expression data. RT- PCR primer
sequences were as follows, Rela: 50-CCTGTCTGCACCTGTTCCAA-
30 (forward), and 50-ACTCCTGGGTCTGTGTTGTT-30 (reverse), Actb:
50-GGAGAA GATTTGGCACCACACT-30 (forward), and 50-
CGGTTGGCCTTA GGGTTCAGA-30 (reverse). The comparative CT
method was performed to measure the relative expression lev-
els of Rela in liver samples. All qRT-PCR data were normalized
after subtracting the CT values of Rela from that of Actb as an
internal control (2-DCT method, DCT¼CTRela – CtActb). Each
measurement was performed in triplicate.
Data analysis
The results were analyzed using Graph Pad Prism (version 5,
Graph Pad Software Inc., La Jolla, CA). Results are presented as
mean±standard deviation for six independent rats per each
group. The statistical significance of the differences between
groups was assessed using one-way analysis of variance, post-
hoc test, and Fisher’s least significant difference (LSD) test.
Results
Protective and therapeutic effect of LIN on CCl4
-induced hepatic and renal histopathological changes
Hepatic changes in control and LIN-administrated showed
normal hepatic architecture illustrated by hepatic lobule with
Figure 1. (a) Photomicrograph of the liver of normal control rats shows a normal hepatic architecture represented by hepatic lobule with a thin walled central vein.
(b) Photomicrograph of the liver of treated rats with CCl4 shows restoration of normal hepatic architecture with disappearance of fat droplets from hepatocyte cyto-
plasm; congestion of the central vein; lymphocytic infiltration; and hydropic degeneration in the hepatocytes, (arrows) and regeneration of hepatic parenchyma. (c)
Photomicrograph of the liver of the CCl4 þ Lin group shows disappearance of most of the degenerative changes. (d) Photomicrograph of the liver of Lin group
shows normal architecture as that of the control group (H&E, 400).
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a thin walled central vein and normal hepatic cords radiating
toward the periphery alternating with hepatic sinusoids. In
the CCl4 group, the livers showed hydropic degeneration in
the hepatocytes, lymphocytic infiltration, and congestion of
the central vein. The liver of the protective and post treat-
ment group (CCl4 plus LIN) demonstrated disappearance of
the degenerative changes in hepatocytes except few hepatic
cells and edema in the central vein showed hydropic degen-
eration (Figure 1(a–d)). The normal kidney in control and LIN-
administered rats showed a normal renal architecture repre-
sented by renal tubules and renal corpuscles (Figure 2(a–d)).
In the CCl4-administered group, renal histology showed con-
gestion of the renal blood vessels, degeneration in the cells
of the proximal and distal convoluted tubules and vacuol-
ation of the renal tubules (Figure 2). In the protective and
posttreatment group, LIN induced recovery and regeneration
in renal structure from biohazards of CCl4 (Figure 2(a–d)).
Correspondingly, histological scores were significantly
decreased to 2.3 and 1.8 in liver and kidney tissues, respect-
ively compared to CCl4-treated group (Figure 3).
Protective and therapeutic effect of LIN on CCl4-induced
changes in serum biochemical profiles, hepatic, and
renal function tests
The results in Figure 4(a–d);liver) and Figure 4(e–h);kidney) show
that oral administration of LIN for 14days increased the serum
levels of ALT, AST, ALP, BUN, creatinine, albumin, bilirubin, and
total protein in serum of CCl4 administered rats compared to
control and LIN administered rats. Co-administration of LIN
together with CCl4 normalized such alterations. Moreover, LIN-
administered rats did not show increase in serum levels of ALT,
AST, ALP, BUN, creatinine, albumin, bilirubin, and total protein.
These data indicated that LIN co-administration with CCl4
restored such alterations to normal levels and LIN has no toxic
effects on hepatic, and renal function parameters.
Protective and therapeutic effect of LIN on CCl4
-induced changes in enzymatic antioxidant defense
systems and MDA content of liver and kidney
As shown in the Table 1, in the CCl4 group, the activity of
serum TAC, CAT, SOD, and GPx was significantly (p< 0.001)
reduced as compared to the control group and LIN group. In
the LINþCCl4 group, linalool could significantly (p< 0.001)
ameliorate the activity of these enzymes compared to the
CCl4 group. Also, administration of linalool (25mg/kg) alone
for 14 days caused a significant (p< 0.001) increase in the
activity of the enzymes as compared to the control group.
Figure 2. (a and d) Photomicrograph of the kidney of normal control and Lin-administered rats shows normal renal architecture represented by renal tubules and
renal corpuscles. (b) Photomicrograph of the kidney of CCL4-administered rats shows congestion of the renal blood vessels, vacuolation of the renal tubules, and
degeneration of the cells of the proximal and distal convoluted tubules. (c) Photomicrograph of the kidney of CCl4 þ Lin group shows recovery of the renal tissue
to normal structure (H&E, 400).
Figure 3. Semi-quantitative analysis of protective and therapeutic effects of Lin
against CCl4 induced the liver and kidney damages. The histological index was calcu-
lated semi-quantitatively using a scale of 0–3: (0) none, (1) mild, (2) moderate, and
(3) severe damage. The results are expressed as mean±standard deviation (SD).p< 0.05 compared with NC group; †p< 0.05 compared with CCl4 group.
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Protective and therapeutic effects of LIN on CCl4
-induced TNF-a and IL-6 productions
We investigated whether LIN decreases the production of the
pro-inflammatory cytokines: TNF-a and IL-6 induced by CCl4.
The toxic effect of CCl4 has resulted in significant (p< 0.05)
higher IL-6, and TNF-a concentrations in liver and kidney tis-
sues as compared to the control group. However, pretreat-
ment with 25mg/kg LIN caused significantly (p< 0.05) lower
concentrations of these inflammatory in these liver and kid-
ney tissues than those not treated (Figure 5(a,b)).
Figure 4. Protective and therapeutic effects of Lin on CCl4 induce changes in the liver and kidney function with evaluation of (a) AST, (b) ALT , (c) ALP, (d) liver
albumin, (e) Creatinine, (f) BUN, (g) total bilirubin, and (h) kidney albumin using commercially available kits. The results are expressed as mean ± standard deviation
(SD) for the rats in each group.  Shows the significance of the differences relative to the normal control group (p< 0.001). ††† Shows the significance of the dif-
ferences relative to CCl4 group (p< 0.001).
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Protective and therapeutic effect of LIN on CCl4
-induced changes in hepatic nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-jB) expression
Administration of CCl4 with single dose increased mRNA
expression of NF-jB (Figure 6). LIN alone decreased the
expression of NF-jB. Co-administration of LIN and CCl4 nor-
malized such increase in NF-jB expression reported in CCl4
group. These results indicate that co-administration of LIN
with CCl4 decreases NF-jB.
Discussion
Acute and chronic exposure to some organic solvents is
known to cause hepatotoxicity and nephrotoxicity
(Malaguarnera et al. 2012). In the past of several decades, oxi-
dative stress has been found to be the man mechanism of
action of a number of some solvent (Kum et al. 2007).
Solvents are highly lipophilic, which rapidly absorb and dis-
tribute in the body (Fiserova-Bergerova 1985). The presence
of the enzymatic systems necessary for solvent metabolism
and the high levels of transition metals found in the liver
and kidney have led to the oxidative stress in toxicity these
agents (Brautbar and Williams II 2002, Al-Ghamdi et al. 2003).
A number of enzymes might be responsible for an associ-
ation between and oxidative stress and solvent exposure
(Costa et al. 2006). One of the main enzyme systems in acti-
vation of solvent to reactive metabolite is cytochrome P450
enzymes which use molecular oxygen to oxidize some
organic solvents (Furge and Guengerich 2006). This oxidation
of solvents produces reactive oxygen species, especially very
reactive intermediate of hydroxyl radical. In turn, hydroxyl
radicals react with many cellular components such as pro-
teins, polyunsaturated fatty acids, nucleic acids.
Concentrations of cytochrome P450 are high in hepatic and
renal tissue, and can be induced by xenobiotics, including
Figure 5. Protective and therapeutic effects of Lin on CCl4 induce changes in the production of TNF-a and IL-6 in liver tissue of Wistar rats using commercially avail-
able kits. The results are expressed as mean ± standard deviation (SD) for the rats in each group.  Shows the significance of the differences relative to the normal
control group (p< 0.001). ††† Shows the significance of the differences relative to CCl4 group (p< 0.001).
Table 1. Protective and therapeutic effect of linalool (Lin) on CCL4 induced changes in hepatic and renal MDA, TAC, and antioxidant enzymes (SOD, GPX, and
CAT) activity.
Experimental groups NC Lin CCL4 Pre-Lin Post-Lin
Liver
MDA (nmol/mg protein) 0.10 ± 0.014 0.11 ± 0.012 0.34 ± 0.027 0.10 ± 0.013 ††† 0.13 ± 0.012†††
TAC (mmol/liter) 0.41 ± 0.05 0.41 ± 0.05 0.22±.04 0.39 ± 0.05††† 0.34 ± 0.04†††
SOD (U/mg protein) 11.05 ± 0.54 11.07 ± 0.54 7.8 5 ± 0.15 8.55 ± 0.17†† 7.92 ± 0.49
GPx (U/mg protein) 4.69 ± 0.44 4.78 ± 0.40 3.39 ± 0.49 4.58 ± 0.40††† 3.83 ± 0.40
CAT (U/mg protein) 86.17 ± 10.71 89.15 ± 10.66 41.84 ± 14.00 66.88 ± 10.81†† 58.87 ± 15.66†
Kidney
MDA (nmol/mg protein) 2.2 ± 0.122 1.7 ± 0.20 24 2.2 ± 2.1 13.06 ± 1.11††† 9.9 ± 1.8†††
TAC (mmol/liter) 414.8 ± 43 409.03 ± 45 263.8 ± 39 356.2 ± 47††† 371. 7 ± 41†††
The results presented in the table are expressed as mean ± standard deviation (SD) for the rats in each group. Shows the significance of the differences relative to the normal control group (p< 0.001).
†, ††, and ††† Show the significance of the differences to CCl4 group (p< 0.05, 0.01, and 0.001, respectively).
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organic solvents (Pelkonen et al. 2008). Therefore, these
enzymes play an important role in transforming organic sol-
vents that have exposed with the liver and kidney. Finally,
this can lead to oxidative stress with the production of free
radicals and lipid peroxidation in the hepatic and renal tis-
sues. CCl4 as an organic solvent and agent in induction of
liver and kidney damage mode, is activated by cytochrome
P450, to form the trichloromethyl radical, CCl3.
Trichloromethyl radical can bind to nucleic acids, proteins,
and lipids. Our result in the current study showed that expos-
ure with CCl4 led to oxidative stress and lipid peroxidation in
hepatic and renal tissues. These data are consistent with pre-
viously published data examining effect of CCl4 on liver and
kidneys (Muriel 1998, Tirkey et al. 2005). Due to the import-
ance of the cytochrome P450 enzymes in activation of xeno-
biotics, assessment of the potential of compounds which
reversibly inhibit cytochrome P450 enzymes can be an
important strategy in reduction of toxicity. Previous studies
have been suggested that linalool is weak competitive inhib-
ition of cytochrome P450 enzymes in rat liver microsomes
(Ganzera et al. 2006, Noskova et al. 2016), therefore, this com-
pound can reduce the toxicity of substances that exert their
toxicity from this pathway. In our study, pretreatment and
post treatment with linalool showed a significant decrease in
CCl4-induced oxidative paraments. Probably inhibition of the
cytochrome P450 by linalool could be effective in creating
this effect.
There is powerful evidence that reactive species (RS) is
involved in oxidative stress as a main mechanism by which
industrial solvents induce liver and kidney damages (Jyothi
et al. 2012). Due to RS high reactivity, these intermediates
prone to cause damage to any type of molecule within the
cell (Bergamini et al. 2004). Due to oxidative damages to the
cellular components, the antioxidant defense in the human
body becomes overwhelmed and lead to toxicity responses
such adaptive, inflammatory, reparative and injurious proc-
esses (Kehrer and Klotz 2015). Oxidative stress has been con-
sidered to be closely associated with nuclear factor (NF)-jB
(Niederberger and Geisslinger 2008). A vicious cycle has been
reported between the oxidative stress and NF-jB pathway.
For the activation of the NF-jB signaling pathway, oxidative
stress is crucial, it results in the aggravation of oxidative
stress (Morgan and Liu 2011).Our results at gen, molecular
cellular and tissue levels showed that exposure with indus-
trial solvent CCL4 caused all toxicity responses mentioned in
above and created a state of oxidative stress condition in
these two organs. Today, antioxidants as potential medical
countermeasures are used for toxic industrial chemicals
(McElroy and Day 2016). Many of these agents produce anti-
oxidant properties indirectly or even paradoxically
(Devasagayam et al. 2004). Direct acting antioxidants that
scavenge reactive species may often generate a reactive
product (Winterbourn 2008). This condition happens with
SOD that dismutate superoxide and produces hydrogen per-
oxide (Ighodaro and Akinloye 2018). Previous studies have
demonstrated the high antioxidant potential of linalool on
reactive species scavenging in comparison with ascorbic acid
(Seol et al. 2016). These studies confirmed that the linalool
can be used in the synthesis of several type of compound
with ability to act as antioxidant (Jabir et al. 2018). They sug-
gested that linalool as a medicine drug can be used in the
treating several types disease related to oxidative stress (Seol
et al. 2016). Our results confirmed that the linalool has pro-
tective and therapeutic effect against CCl4-induced hepatic
and liver damages.
Exposure to drugs, chemicals, mechanical, and thermal
injuries cause inflammation as a tightly regulated immune-
protective response to combat these agents (Kidd and Urban
2001). Our results showed that CCL4 induces the production
of pro-inflammatory cytokines such as IL-6, and TNF-a from
liver and kidney tissues which these data are consistent with
previously published data in this regard (Dai et al. 2018b).
Inhibition of inflammation is always one of the most
important actions in controlling the toxicity effect of these
factors. Nonsteroidal anti-inflammatory drugs (NSAIDs) are
used to suppress prostaglandin E2 (PGE2) production
through the inhibition of cyclooxygenase-2 (COX-2). There is
a strong evidence that have shown, the prolong exposure to
this drug class has been associated with serious and some-
times life-threatening side effects (Mbonye et al. 2008).
Hence it is necessary to find out alternative anti-inflammatory
agents with comparative or more efficacy than NSAIDs but
with fewer side effects. All kinds of inflammatory conditions
have been treated with the natural products. These natural
products later become the counter stones for producing that
main ani-inflammatory drug such as Aspirin. Therefore, the
exploration in the natural products to find out the bioactive
compounds can be quite promising and resulting in the dis-
covery of numinous secondary metabolites with extra ordin-
ary bioactivities (Attiq et al. 2018). Our results showed that
linalool can inhibit the expression and production against
CCl4-induced induction of inflammatory mediators.
Figure 6. Protective and therapeutic effects of Lin on CCl4 induce changes in
the expression of NF-kB in liver tissue of Wistar rats using semi-quantitative RT-
PCR analysis. RNA was extracted and reverse transcribed and RT-PCR analysis
was carried out NF-kB expression as described in materials and methods. The
results are expressed as mean ± standard deviation (SD) for the rats in each
group.  Shows the significance of the differences relative to the normal con-
trol group (p< 0.001). ††† Shows the significance of the differences relative to
CCl4 group (p< 0.001).
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Conclusion
In conclusion, the present study was designed to yield quan-
titative evidence of the protective and therapeutic properties
of linalool against CCl4-induced hepatic and renal damages.
The positive effects of linalool such reduction of oxidative
stress and expression of anti-inflammatory mediators and
enhancement of antioxidant defense were proved in this
study. However, further studies are needed to clarify the
mechanism of the protective and therapeutic effect of lina-
lool against liver and kidney damages. To our knowledge,
this is the first evidence that linalool protects and ameliorates
against CCl4-induced acute hepatotoxicity and nephrotoxicity.
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